Evolent Health, Inc. (NYSE:EVH) Q1 2026 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the First Quarter ended March 31, 2026. As a reminder, this conference call is being recorded.
Evolent Health Inc. (EVH)
Market is closed
Sector: Services-Management Services
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cadian Capital Eric Bannasch | 10,814,473 | $58,614,444 | 4.44% | |
| 2. | Engaged Capital Glenn W. Welling | 5,563,912 | $30,156,403 | 9.22% | |
| 3. | D E Shaw D. E. Shaw | 5,107,561 | $27,682,981 | -7% | 0.01% |
| 4. | 29,987,000 | $22,384,658 | +25% | 0.68% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 3,413,245 | $18,499,786 | +335% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.82 | 10,000 | $38,199.00 | 58,821 | 2025-11-18 | Filing | |
| $9.33 | 2,735 | $25,517.55 | 70,584 | 2025-03-06 | Filing | |
| $9.01 | 11,040 | $99,470.40 | 389,004 | 2025-03-06 | Filing | |
| $9.09 | 15,000 | $136,350.00 | 15,000 | 2025-03-07 | Filing | |
| $9.16 | 15,000 | $137,400.00 | 15,000 | 2025-03-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.00 | 4,000 | $132,000.00 | 188,340 | 2024-08-23 | Filing | |
| $32.00 | 6,469 | $207,008.00 | 192,340 | 2024-08-23 | Filing | |
| $33.00 | 7,000 | $231,000.00 | 198,809 | 2024-08-22 | Filing | |
| $30.00 | 16,693 | $500,790.00 | 205,809 | 2024-08-22 | Filing | |
| $30.00 | 16,887 | $506,610.00 | 167,027 | 2024-08-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 128,850,000 | $96,278,768 | 0.5% | |
| 2. | 14,814,851 | $80,296,492 | 0% | |
| 3. | 79,871,000 | $59,599,666 | 1.16% | |
| 4. | 8,969,012 | $48,612,048 | 0% | |
| 5. | 6,245,283 | $33,849,434 | 0% |
News See All
Evolent Health, Inc. (NYSE:EVH) Q4 2025 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the Fourth Quarter ended December 31, 2025. As a reminder, this conference call is being recorded.
Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion
Evolent Health, Inc. (NYSE:EVH) is one of the best NYSE penny stocks to buy now. On January 7, Citi cut its price target for Evolent Health, Inc.
14 Best NYSE Penny Stocks to Buy Now
Small-cap and penny stocks are having a moment at the start of the new year.
Evolent Health (EVH) Sells ACO Unit, Strengthens Balance Sheet
Evolent Health, Inc. (NYSE:EVH) is one of the best healthcare AI stocks to buy now. On December 8, Evolent Health, Inc.
11 Best Healthcare AI Stocks to Buy Now
On August 13, 2025, the World Economic Forum (WEF) published an analysis exploring how AI is transforming healthcare.
Evolent Health (EVH) Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in Medicare/Medicaid Membership
Evolent Health Inc. (NYSE:EVH) is one of the stocks that will double in 2026.
20 Stocks That Will Double in 2026
On December 8, Kevin Mahn of Hennion & Walsh appeared on CNBC's 'Closing Bell Overtime' to discuss the potential for another bullish year, but with more volatility.
Evolent Health, American Oncology Network Partner to Streamline Cancer Care
Evolent Health Inc. (NYSE:EVH) is one of the best NYSE penny stocks to invest in right now. On November 6, Evolent Health and American Oncology Network announced a new national partnership.
13 Best NYSE Penny Stocks to Invest in Right Now
On November 12, Scott Chronert, Citi US equity strategist, joined CNBC's 'The Exchange' to discuss why he favors the small and mid-cap stocks and what spurs the earnings growth in smaller stocks.
Hedge Fund Resource Center